tm logo
Live/Registered
REGISTERED

on 08 Aug 2023

Last Applicant/ Owned by

Koto-ku Tokyo 136-0075

JP

Serial Number

79355199 filed on 28th Sep 2022

Registration Number

7129133 registered on 08th Aug 2023

in the Principal Register

Correspondent Address

M. Scott Alprin

Alprin Law Offices, P.C.

5 Pinehurst Circle, N.W.

Washington DC 20015

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

Logo Mark Trademark Information

Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights

Class [042]
Computer & Software Services & Scientific Services


Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances

Class [040]
Treatment & Processing of Materials Services


Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes

Class [001]
Chemical Products


Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents

Mark Details


Serial Number

No 79355199

Mark Type

No Service Mark

Attorney Docket Number

No 0332003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

01.01.07 -

Stars with tails or comets

26.01.29 -

Helixes

Description of Design Search

The mark consists of two wavy lines resembling double-stranded DNA in navy together with three comet-like figures in orange. The white in the mark is background only and is not claimed as a feature of the mark.

Legal History


Show more

Status DateAction Taken
14th Nov 2023FINAL DISPOSITION PROCESSED
14th Nov 2023FINAL DISPOSITION NOTICE SENT TO IB
08th Nov 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08th Aug 2023REGISTERED-PRINCIPAL REGISTER
08th Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
24th May 2023NOTIFICATION PROCESSED BY IB
23rd May 2023PUBLISHED FOR OPPOSITION
23rd May 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03rd May 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd May 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB